Clinical
RSSArticles
-
Elagolix (Orilissa)
Elagolix is indicated for the management of moderate to severe pain associated with endometriosis.
-
Treatment of Chronic Subdural Hematoma With Atorvastatin
The results of a recent study suggest that atorvastatin may be a safe and effective nonsurgical alternative for patients with chronic subdural hematoma.
-
Inappropriate Outpatient Antibiotic Prescribing: The Need to Target Urgent Care Centers
Urgent care centers, which are part of a growth industry, are responsible for a large proportion of antibiotic prescriptions, including inappropriate prescriptions for acute respiratory diagnoses.
-
Latent Tuberculosis Treatment With 4 Months of Rifampin Compared to 9 Months of Isoniazid
In an open-label trial, adults with latent tuberculosis infection were randomized to either four months of treatment with rifampin or nine months of treatment with isoniazid. The four-month rifampin regimen was non-inferior to nine months of isoniazid for prevention of active tuberculosis.
-
Vitamin C for Postoperative Atrial Fibrillation Risk
Vitamin C supplementation decreases the risk of developing postoperative atrial fibrillation.
-
Use of Amyloid PET Imaging for Diagnosis of Dementia
The use of amyloid PET scanning to assist in accurate diagnosis of patients with symptoms of cognitive impairment as well as frank dementia results in a change of diagnosis in at least 25% of patients.
-
Does Every Woman Deserve a High-volume Gynecologic Surgeon?
Generally, gynecologic surgical complications are higher with lower-volume surgeons.
-
Vaginal Progesterone vs. Cerclage to Prevent Preterm Birth
SYNOPSIS: A recent indirect comparison meta-analysis has shown that vaginal progesterone is as useful in decreasing preterm birth and its associated adverse outcomes as cervical cerclage in patients with a history of preterm birth and short cervices.
-
Intrauterine Devices and Cervical Cancer
In this case-control study, levonorgestrel IUD use was associated with a slightly increased rate of CIN 2 but not CIN 3. Copper IUD use was not associated with CIN 2 or CIN 3.
-
Primary HPV Screening: Ready for Prime Time?
In this randomized, controlled trial of more than 25,000 women, participants with negative high-risk human papillomavirus testing at baseline had rates of CIN 3+ at 48 months that were lower compared to negative liquid-based cytology testing.